Ursachen und Prävention von Folgeerkrankungen des Diabetes – Ein Update zur Deutschen Diabetes-Studie (DDS)

Zusammenfassung

Die Entwicklung des Typ-1- und Typ-2-Diabetes und deren Folgeerkrankungen stellen ein komplexes Geschehen dar. Hierbei spielen beispielsweise Umwelteinflüsse und individuelle genetische Voraussetzungen eine Rolle. Die Interaktion verschiedener Faktoren, die diese Krankheiten beeinflussen, wird in der Deutschen Diabetes-Studie (DDS) – einer der 3 großen Multicenterstudien des Deutschen Zentrums für Diabetesforschung (DZD) – untersucht. Ziel ist es, den Krankheitsverlauf besser zu verstehen, um daraus Interventionen zur Vorbeugung von Folgeschäden abzuleiten.

Summary

The development of type 1 and type 2 diabetes and their secondary diseases constitute a complex series of events. For example, environmental factors and individual genetic predispositions play a part in the process. The interactions between various factors that influence these diseases were studied in the German Diabetes Study [Deutschen Diabetes-Studie (DDS)] – one of the 3 large multicenter studies of the German Center for Diabetes Research [Deutschen Zentrum für Diabetesforschung (DZD)]. The target is to better understand the course of the disease in order to deduce interventions aimed at reducing or preventing secondary damages.

Key words

Diabetes - secondary diseases - preventing secondary damages

• Literatur

• 1 Nowotny B, Nowotny PJ, Strassburger K, Roden M. Precision and accuracy of blood glucose measurements using three different instruments. Diabet Med 2012; 29: 260-265
• 2 Kahl S, Nowotny B, Piepel S, Nowotny PJ, Strassburger K, Herder C, Pacini G, Roden M. Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial. Diabetologia 2014; 57: 2094-2102
• 3 Schadewaldt P, Nowotny B, Strassburger K, Kotzka J, Roden M. Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability. Am J Clin Nutr 2013; 97: 763-773
• 4 Laufs A, Livingstone R, Nowotny B, Nowotny P, Wickrath F, Giani G, Bunke J, Roden M, Hwang JH. Quantitative liver 31P magnetic resonance spectroscopy at 3T on a clinical scanner. Magn Reson Med 2014; 71: 1670-1675
• 5 Ziegler D, Papanas N, Roden M. GDC Study Group. Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet Med 2011; 28: 1412-1425
• 6 Ziegler D, Papanas N, Zhivov A, Allgeier S, Winter K, Ziegler I, Brüggemann J, Strom A, Peschel S, Köhler B, Stachs O, Guthoff RF, Roden M. German Diabetes Study (GDS) Group. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 2014; 63: 2454-2463
• 7 Strom A, Brüggemann J, Ziegler I, Jeruschke K, Weiss J, Al-Hasani H, Roden M, Ziegler D. GDS Group. Pronounced reduction of cutaneous Langerhans cell density in recently diagnosed type 2 diabetes. Diabetes 2014; 63: 1148-1153
• 8 Menart-Houtermans B, Rütter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, Simon MC, Szendroedi J, Schloot NC, Roden M. German Diabetes Study Group. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 2014; 37: 2326-2333
• 9 Nowotny B, Zahiragic L, Bierwagen A, Kabisch S, Groener JB, Nowotny PJ, Fleitmann AK, Herder C, Pacini G, Erlund I, Landberg R, Haering HU, Pfeiffer AF, Nawroth PP, Roden M. Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial. Diabetologia 2015; 58: 255-264